Zhang Xiaoyan, Sun Wei, Shang Shiqiang, Mao Jianhua, Fu Junfen, Shu Qiang, Jiang Kewen
BioBank of Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310051, China.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):170-177. doi: 10.3785/j.issn.1008-9292.2020.02.04.
Coronavirus disease 2019 (COVID-19) is a grade B infectious disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In pace with the spreading of the disease, biosafety risk of the biological specimen preservation in biobanks has been significantly increased and biosafety protection during biological specimen preservation become increasingly important. According to the related national rules and the corresponding guidelines of Chinese Medical Association, this paper introduced the etiology about SARS-CoV-2, epidemiology about COVID-19, and the biosafety protection principles of individuals and biological specimen storage places in the process of personal protection, protection of collection, transport, handling, preservation, detection, post-detection disposal and emergencies of biological specimen. Emphasized to carry out a strict biosafety-risk assessment on biological specimen basing on virus load information, infectivity, and sample type (possible contact transmission, aerosol transmission, and fecal oral transmission).
2019冠状病毒病(COVID-19)是由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的乙类传染病。随着该疾病的传播,生物样本库中生物样本保存的生物安全风险显著增加,生物样本保存期间的生物安全防护变得日益重要。依据国家相关规定及中华医学会的相应指南,本文介绍了SARS-CoV-2的病原学、COVID-19的流行病学,以及在个人防护、生物样本采集、运输、处理、保存、检测、检测后处置及应急情况等过程中个人及生物样本储存场所的生物安全防护原则。强调应基于病毒载量信息、传染性及样本类型(可能的接触传播、气溶胶传播和粪口传播)对生物样本进行严格的生物安全风险评估。